Global Economic Intersection
Advertisement
  • Home
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
  • Home
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
Global Economic Intersection
No Result
View All Result

Why Cancer Won’t Be Deadly in 15 Years

admin by admin
June 14, 2014
in Uncategorized
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

by Paul Mampilly, Daily Reckoning

“We’re going to chop off your tongue.”

That’s what they told him when he went to see the cancer surgeon.

They told him that they were going to chop off his tongue and put a muscle from another part of his body in its place.

And even if this tongue amputation worked, the cancer surgeon told him, he stood only a 50% chance of living for another two years.

But that didn’t scare him. He told his doctors what he really feared was losing his incredible ability to taste food, eat it and use this sensibility to make food for other people to eat.

“I lived my whole life in the kitchen. Not only that, but it’s the passion, it’s the love for cooking and food. It’s dictated my entire life – every aspect of it. So in some ways, the thought of not being able to do that anymore radically affects your life.”

I’ll tell you in a minute whom I am talking about and why this story matters so much. But first…

The American Society of Clinical Oncology (ASCO) meeting in Chicago is the Burning Man – or if you’re older, the Woodstock – of medical conferences in the United States. This year, an estimated 25,500 attended. Although I can personally say it felt as if there were 50,000 people there.

If this seems trivial to you, just imagine nearly 30,000 of the most elite doctors, scientists and businesspeople involved in treating cancer, researching cancer medicines and making cancer drugs all in one place at the same time. If a terrorist planted a bomb at the convention center, the world’s knowledge of cancer would be set back by at least 20 years.

in 15 years… cancer is going to get knocked down to the status of a chronic disease.

Plus, there were 400 sponsors (companies that sell drugs, services or devices for cancer patients) along with patient advocacy groups and other nonprofit medical groups.

At the conference this year, I read through over 100 abstracts on drugs and treatments that are currently being developed for cancer patients. I also attended 12 presentations with subjects ranging from limb-saving surgery versus amputation in sarcomas (in bone cancer) to glioblastomas (in brain cancer) to molecular targeting and immunotherapy.

By the end of the conference, I came to this stunning realization:

Cancer won’t be a death sentence for much longer.

At the conference, I spoke with some of the country’s most elite oncologists (cancer doctors). The doctors are the ultimate judges of how good these drugs are, because they are the ones who are dealing with cancer patients every single day. And here’s what these elite doctors were saying at the conference…

“What blew me away – and what should blow you away – are these response rates. This is a truly amazing disease-free survival,” said A. Dimitrios Colevas, MD, of Stanford Cancer Center about the trial results on a drug that’s waiting for FDA approval for use in thyroid cancer.

“It’s been very exciting… A few years ago, we had very little to offer patients, and now many more patients can be cured using these new therapeutic approaches, even if their melanoma [skin cancer] has spread,” said Patrick Hwu, MD, of the University of Texas MD Anderson Cancer Center. He was talking about ipilimumab, a drug that is approved by the FDA for skin cancer.

“If an oncologist practicing in 1964 at the time of ASCO’s founding was placed in a time capsule and transported to the 2014 ASCO Annual Meeting, she could be forgiven for thinking she had arrived in another universe. The landscape of breast cancer management… has changed so dramatically as to be virtually unrecognizable,” said Monica Morrow MD, chief of breast cancer surgery at Memorial Sloan-Kettering Cancer Center.


What is the Income Play Rich Investors Love? (Hint: It’s Tax-Free)


We’re giving you a bird’s-eye view of the ongoing revolution in cancer treatment so that we can better spot early opportunities to invest alongside blockbuster drugs that will save lives… Your life and the lives of your family, your friends and countless others you haven’t met yet or don’t even know.

Because in 2014 alone, there are going to be 1,665,540 people like you and me diagnosed with cancer, and 585,720 of us are going to die from it.

I’m not saying this to scare you. I’m saying this because simply nobody in their right mind can argue that cancer is not a clear and present danger to every single one of us living today. Why am I so sure?

Because one out of every four of us is going to die from cancer. Right now, cancer is the second most common cause of death in the U.S. And guess what? Fighting cancer is righteous, and it’ll only take one friend or family member to get you onboard this growing cause.

On Sunday, June 1, the third day of the ASCO conference, I went to Chicago’s funky meatpacking district in search of a secret restaurant called the Aviary. The Aviary is owned and run by Grant Achatz. Grant Achatz was rated as the best chef in America in 2008. His other Chicago restaurant, Alinea, is currently rated as one of the best 10 restaurants in the world. Yes, that’s right, the world.

And Achatz is the chef whose tongue the cancer surgeons wanted to replace.

If you like great food, you’ll be happy to hear that Grant rejected the surgeon’s advice to cut his tongue off. Grant instead chose an experimental therapy at the University of Chicago, where they treated him with radiation and chemotherapy. Now, this experimental treatment still burned Grant’s tongue and made him shed the lining of his esophagus (the esophagus is the tube that carries food, liquids and saliva from the mouth to the stomach). So while Grant saved his tongue, this experimental treatment utterly and completely killed his taste buds.

But the treatment worked. And his cancer went into remission. Best of all for Grant, he still had his tongue. And with his tongue still in his mouth, Grant kept the hope that one day he might have a chance to taste again.

Achatz is still alive today. His cancer has been in remission for seven years. And some time after the radiation and chemotherapy was finished, his taste buds slowly started coming back. His flavor sense came back one day at a time.

Grant said:

“I started from zero, and the first thing back was sweet. So my palate developed just as a newborn – but I was 32 years old. So I could understand how flavors were coming back and how they synergized together… It was very educational for me. I don’t recommend it, but I think it made me a better chef because now I really understand how flavor works.”

If you want to know more about Grant Achatz, read his book Life, on the Line: A Chef’s Story of Chasing Greatness, Facing Death and Redefining the Way We Eat.

So what does Grant Achatz’s cancer have to do with anything?

You see, the quantity and quality of drugs in development that I saw being presented at ASCO this year virtually guarantees that the next time a talented chef like Achatz gets tongue cancer, he won’t be given a choice between cutting his tongue out or burning it.

Instead, a doctor will take a small tissue sample of his cancer tumor. Next, a lab will match his cancer tumor to see which specific cancer gene molecule is causing it. And then he’ll get a drug that’s designed precisely to knock out the cancer gene molecule causing the cancer.

Now, don’t misunderstand me, because we’re not to this point yet, but each year, five more of these kinds of targeted cancer drugs are going to become available to patients. And each year, these drugs are going to become more effective and less toxic.

I predict that in 15 years, most of us will simply take a pill or get an injection and live with our cancers. In other words, cancer is going to get knocked down to the status of a chronic disease. By chronic, I mean that you’ll take a medicine for your cancer and lead a normal, productive life.

Keep your eye on this space!

Previous Post

Weekend Market Commentary: Special Edition

Next Post

Adullamites

Related Posts

Judge Dismisses Proposed Class-Action Suit Claiming Coinbase Securities Sales
Business

Judge Dismisses Proposed Class-Action Suit Claiming Coinbase Securities Sales

by John Wanguba
February 2, 2023
Aesop Targeted In $2bn Bidding War Between French Groups
Business

Aesop Targeted In $2bn Bidding War Between French Groups

by John Wanguba
February 1, 2023
EU Wants To Ease State Aid Regulations To Boost Renewables Investment
Business

EU Wants To Ease State Aid Regulations To Boost Renewables Investment

by John Wanguba
February 1, 2023
Philippines To Offer Value-Added Tax Refund To Foreign Visitors By 2024
Economics

Philippines To Offer Value-Added Tax Refund To Foreign Visitors By 2024

by John Wanguba
January 31, 2023
Bitcoin Mining Revenue Rises 50% To $23M In A Month
Business

Bitcoin Mining Revenue Rises 50% To $23M In A Month

by John Wanguba
January 30, 2023
Next Post

Adullamites

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Browse by Tags

adoption altcoins banking banks Binance Bitcoin Bitcoin adoption Bitcoin market Bitcoin mining blockchain BTC business China crypto crypto adoption cryptocurrency crypto exchange crypto market crypto regulation decentralized finance DeFi Elon Musk ETH Ethereum Europe finance FTX inflation investment market analysis markets Metaverse mining NFT nonfungible tokens oil market price analysis recession regulation Russia technology Tesla the UK the US Twitter

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • August 2010
  • August 2009

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized
Global Economic Intersection

After nearly 11 years of 24/7/365 operation, Global Economic Intersection co-founders Steven Hansen and John Lounsbury are retiring. The new owner, a global media company in London, is in the process of completing the set-up of Global Economic Intersection files in their system and publishing platform. The official website ownership transfer took place on 24 August.

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Recent Posts

  • Judge Dismisses Proposed Class-Action Suit Claiming Coinbase Securities Sales
  • Aesop Targeted In $2bn Bidding War Between French Groups
  • EU Wants To Ease State Aid Regulations To Boost Renewables Investment

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.

No Result
View All Result
  • Home
  • Contact Us
  • Bitcoin Robot
    • Bitcoin Profit
    • Bitcoin Code
    • Quantum AI
    • eKrona Cryptocurrency
    • Bitcoin Up
    • Bitcoin Prime
    • Yuan Pay Group
    • Immediate Profit
    • BitIQ
    • Bitcoin Loophole
    • Crypto Boom
    • Bitcoin Era
    • Bitcoin Treasure
    • Bitcoin Lucro
    • Bitcoin System
    • Oil Profit
    • The News Spy
    • British Bitcoin Profit
    • Bitcoin Trader
  • Bitcoin Reddit

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.

en English
ar Arabicbg Bulgarianda Danishnl Dutchen Englishfi Finnishfr Frenchde Germanel Greekit Italianja Japaneselv Latvianno Norwegianpl Polishpt Portuguesero Romanianes Spanishsv Swedish